MDQK.HM MediNavi jumps 200% to €7.50 on HAM 19 Mar 2026: high-volume catalyst

MDQK.HM stock surged 200.00% to €7.50 during market hours on 19 Mar 2026, marking it as a top high-volume mover on HAM. The move came from a low-liquidity base: intraday range €2.50–€7.50 with 35 shares traded versus an average of 41. MediNavi AG (MDQK.HM) shows thin trading history and limited public financials, so price swings can be extreme. We break down the intraday action, fundamentals, technicals, Meyka AI grade, and a practical trading framework for investors tracking this high-volume mover on the Germany exchange.

MDQK.HM stock: intraday price and volume snapshot

MDQK.HM stock closed at €7.50 after opening at €2.50 on HAM on 19 Mar 2026. The reported one-day change was +€5.00 or +200.00%. Volume was 35 shares against an average volume of 41, highlighting very thin liquidity.

The 50-day average price is €2.50 and the 200-day average is €1.99, so today’s price sits well above both averages. Day low was €2.50 and day high matched the close at €7.50, signalling a single-session re-rating in a low-trade environment.

MDQK.HM stock: likely drivers behind the move

There is no earnings release or formal company announcement timestamped in public filings on 19 Mar 2026. MDQK.HM earnings and formal EPS data are not available, which increases sensitivity to sparse corporate signals.

Analyst consensus points to three likely drivers: thin free float magnifying small orders, a speculative buy triggered by third‑party mentions, or a private placement/corporate action that has yet to appear in filings. Investors should treat the move as liquidity-driven rather than fundamentals-driven until official disclosure appears. For company details visit the MediNavi website source.

MDQK.HM stock: fundamentals and valuation context

MediNavi AG operates in Healthcare, specifically Medical – Healthcare Information Services, but public financial metrics are sparse. Reported EPS and P/E are null and market cap is shown as 0, indicating missing market‑cap data or unreported shares outstanding.

Key balance metrics show a very high current ratio of 41.50 and working capital of €269,922.60, suggesting cash or short-term assets on the books. Enterprise value is negative -€255,031.00, reflecting data gaps. Compare this to the broader Healthcare sector, which has an average current ratio near 2.74 and typical P/E around 29.15.

MDQK.HM stock: technicals, volatility and Meyka AI grade

Technical indicators are distorted by thin trading. ATR is 5.00, reflecting large price swings. The 50-day average price €2.50 and 200-day average €1.99 show recent upward drift before today’s spike.

Meyka AI rates MDQK.HM with a score out of 100: 62.55 / 100, Grade B, Suggestion HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst consensus. The grade should be read as an informational metric; it is not investment advice.

MDQK.HM stock: trading strategy and risk management for high-volume moves

For traders, MDQK.HM stock presents high reward and high risk because of limited liquidity and opaque fundamentals. Use small position sizes, strict stops, and limit orders to control execution price.

Recommended tactical levels: consider a short-term profit target near €9.00, a conservative re‑entry target near the 50‑day average €2.50, and a protective stop below €2.50 if the trade is speculative. Always confirm any corporate news or filings before adding exposure.

MDQK.HM stock: sector signals and market context

Healthcare sector performance is muted year-to-date with 1Y performance around -3.77% and a typical sector P/E near 29.15. MediNavi’s intraday spike contrasts with sector trends and underlines firm-specific liquidity rather than sector strength.

Given MediNavi’s listing on HAM in Germany and limited analyst coverage, investors should weigh broader Healthcare multiples against the company’s missing earnings and thin trade profile.

Final Thoughts

MDQK.HM stock’s 200.00% intraday jump to €7.50 on HAM on 19 Mar 2026 is a clear high-volume mover driven more by liquidity dynamics than by transparent fundamental news. The company lacks reported EPS and a definitive market cap in public feeds, so price swings can be abrupt. Meyka AI’s forecast model projects a 12‑month base case target of €8.50, implying +13.33% from the current price of €7.50, with a bull case of €12.00 (+60.00%) and a bear case of €2.00 (-73.33%). Forecasts are model-based projections and not guarantees. Traders should use tight risk controls, verify any corporate filings, and treat intraday spikes in MDQK.HM as speculative until clear company disclosures appear. For more on MediNavi AG, see the company site source and exchange details at Boerse Hamburg. Meyka AI provides this as an AI-powered market analysis platform and not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.